Statin therapy eligibility in a large primary prevention cohort according to European Society of Cardiology Guidelines

25 April 2024 (09:00 - 12:30)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Doctor Marie Hauguel-Moreau

University Hospital Ambroise Pare, Boulogne-Billancourt (France)

9 More presentations in this session

Presentation thumbnail

Feasibility and preliminary effectiveness of a population health management approach to improve cardiovascular risk management in primary care: a mixed-method implementation study

Ms M. Rakers (Leiden, NL)

Abstract Slides

Presentation thumbnail

Life essential 8 associated with a lower risk of stroke: ideal cardiovascular health in the EPIC-NL prospective cohort study

Assistant Professor A. Uijl (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Potentially avoidable hospitalizations for heart failure in Switzerland

Doctor K. Maung (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Mixed messages? Information about cardiovascular health and alcohol use: a cross-sectional study of patients in cardiology care

Doctor S. Wallhed Finn (Stockholm, SE)

Abstract Slides

Presentation thumbnail

Attainment of guideline recommended cholesterol goals in cardiovascular prevention results from a preventive cardio-rheuma clinic in norway

Doctor A. Semb (Oslo, NO) Miss E. Sollerud (Oslo, NO)

Abstract Slides

Access the full session

Session thumbnail

Delivering patient-centered prevention population-wide

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

You may be interested in

Congress Presentation

Lipid control in cardiovascular patients

Congress Presentation

Fix the plaque, fight the lipids: why low-density lipoproteins still matter after percutaneous coronary intervention

Congress Presentation

What’s new in LDL lowering?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources